- Home
- APWC vs ICCC Comparison
APWC vs ICCC Comparison
Compare APWC & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APWC
- ICCC
- Stock Information
- Founded
- APWC 1996
- ICCC 1982
- Country
- APWC Taiwan
- ICCC United States
- Employees
- APWC N/A
- ICCC N/A
- Industry
- APWC Telecommunications Equipment
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- APWC Industrials
- ICCC Health Care
- Exchange
- APWC Nasdaq
- ICCC Nasdaq
- Market Cap
- APWC 38.9M
- ICCC 45.9M
- IPO Year
- APWC 1997
- ICCC 1987
- Fundamental
- Price
- APWC $1.55
- ICCC $5.50
- Analyst Decision
- APWC
- ICCC
- Analyst Count
- APWC 0
- ICCC 0
- Target Price
- APWC N/A
- ICCC N/A
- AVG Volume (30 Days)
- APWC 13.3K
- ICCC 10.0K
- Earning Date
- APWC 08-26-2024
- ICCC 02-25-2025
- Dividend Yield
- APWC N/A
- ICCC N/A
- EPS Growth
- APWC N/A
- ICCC N/A
- EPS
- APWC 0.18
- ICCC N/A
- Revenue
- APWC $468,125,000.00
- ICCC $23,838,001.00
- Revenue This Year
- APWC N/A
- ICCC N/A
- Revenue Next Year
- APWC N/A
- ICCC N/A
- P/E Ratio
- APWC $8.76
- ICCC N/A
- Revenue Growth
- APWC 12.16
- ICCC 46.37
- 52 Week Low
- APWC $1.20
- ICCC $3.34
- 52 Week High
- APWC $2.02
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- APWC 52.05
- ICCC 62.66
- Support Level
- APWC $1.36
- ICCC $4.86
- Resistance Level
- APWC $1.57
- ICCC $5.50
- Average True Range (ATR)
- APWC 0.08
- ICCC 0.35
- MACD
- APWC 0.02
- ICCC -0.01
- Stochastic Oscillator
- APWC 90.48
- ICCC 100.00
About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in owning operating companies engaged in the power cable, telecommunication cable, enameled wire, and electronic cable industry. It also provides project engineering services to customers. Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.